Funds holding REVIVA PHARMACEUTICALS HOLDINGS INC
ISIN US76152G2093 · United States
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 408.4 $
- Share of capital
- 0.0 % of 13.1M shares on Aug 13, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 998 | 408.4 $ | 0.01 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 1 | -2 | 998 | -99.2 % |
| 2026Q2 | 3 | 117,672 |
Institutional managers
32 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 793,948 | 579.3K $ | as of Mar 31, 2026 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 762,236 | 556.2K $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 592,079 | 432K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 261,898 | 191 $ | as of Mar 31, 2026 |
| EMC Capital Management | 128,915 | 44 $ | as of Dec 31, 2025 |
| Warberg Asset Management LLC | 90,772 | 66.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 72,992 | 53.3K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 43,002 | 31.4K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 32,905 | 24 $ | as of Mar 31, 2026 |
| STATE STREET CORP | 19,160 | 14K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 18,582 | 13.6K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 18,423 | 13 $ | as of Mar 31, 2026 |
| Castleview Partners, LLC | 15,694 | 11.5K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 10,715 | 7.8K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 10,469 | 7.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 8,530 | 6.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 5,269 | 3.8K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 3,109 | 2.3K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,193 | 1.6K $ | as of Mar 31, 2026 |
| Sound Income Strategies, LLC | 1,500 | 1.2K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1,219 | 889 $ | as of Mar 31, 2026 |
| Larson Financial Group LLC | 833 | 608 $ | as of Mar 31, 2026 |
| TD Waterhouse Canada Inc. | 625 | 498 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 470 | 343 $ | as of Mar 31, 2026 |
| Purpose Unlimited Inc. | 405 | 288 $ | as of Mar 31, 2026 |
Declared shareholders of REVIVA PHARMACEUTICALS HOLDINGS INC
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Integrated Core Strategies (US) LLC and 3 others | 8.20 % | 1,072,690 | as of Jun 30, 2026 · SCHEDULE 13G |
| Barclays PLC | 0.00 % | 20 | as of Jun 30, 2026 · SCHEDULE 13G |
| UBS Group AG | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding REVIVA PHARMACEUTICALS HOLDINGS INC". https://titelia.com/en/stocks/reviva-pharmaceuticals-holdings-inc-US76152G2093